Track: CME Session

SESSION 5: FIRST-LINE THERAPY DEBATES

Moderator(s)

• 

  Viktor Gruenwald, MD PhD (he/him/his)

  Professor for interdisciplinary GU Oncology
  Essen University Hospital, West German Cancer Center, Clinic for Medical Oncology & Clinical for Urology, Essen, Germany
  University Hospital Essen
  Essen, Germany
• 

  Lisa Pickering, MD, PhD (she/her/hers)

  Consultant Medical Oncologist
  The Royal Marsden NHS Foundation Trust, United Kingdom

Presentations:

• 15:26 – 15:27 GMT

  Introduction to Session 5
  

  Speaker: Viktor Gruenwald, MD PhD (he/him/his) – Essen University Hospital, West German Cancer Center, Clinic for Medical Oncology & Clinical for Urology, Essen, Germany
• 15:27 – 15:37 GMT

  Debate: In favour of IO-TKI Triplets
  

  Speaker: Tian Zhang, MD, MHS (she/her/hers) – University of Texas Southwestern Medical Center

  Speaker: Laurence Albiges, MD, PhD (she/her/hers) – Institut Gustave Roussy
• 15:37 – 15:47 GMT

  Debate: In favour of IO-TKI Doublets
  

  Speaker: Laurence Albiges, MD, PhD (she/her/hers) – Institut Gustave Roussy
• 15:47 – 15:57 GMT

  Debate: In favour of IO-IO
  

  Speaker: Michael B. Atkins, MD (he/him/his) – Georgetown Lombardi Comprehensive Cancer Center, Washington, DC, USA.
• 15:57 – 16:07 GMT

  Optimal toxicity management
  

  Speaker: Kate Young, MBBS, MA, MRCP, MD(Res) (she/her/hers) – Royal Marsden Hospital
• 16:07 – 16:17 GMT

  Illustrative Clinical Scenarios
  

  Speaker: Lisa Pickering, MD, PhD (she/her/hers) – The Royal Marsden NHS Foundation Trust
• 16:17 – 16:30 GMT

  Session 5: Panel discussion and Q&A
  

  Moderator: Viktor Gruenwald, MD PhD (he/him/his) – Essen University Hospital, West German Cancer Center, Clinic for Medical Oncology & Clinical for Urology, Essen, Germany

  Moderator: Lisa Pickering, MD, PhD (she/her/hers) – The Royal Marsden NHS Foundation Trust